SHWETA SHAH to Complement Inactivating Agents
This is a "connection" page, showing publications SHWETA SHAH has written about Complement Inactivating Agents.
Connection Strength
0.235
-
Evaluation of ravulizumab trough levels in pediatric complement-mediated hemolytic uremic syndrome in remission. Pediatr Nephrol. 2026 Jun; 41(6):1753-1760.
Score: 0.235
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.